Annals of Family Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Annals of Family Medicine 6:100-106 (2008)
© 2008 Annals of Family Medicine, Inc.
doi: 10.1370/afm.819

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow In Brief
Right arrow TRACK Discussion: Submit a Comment
Right arrow TRACK Discussion: View Comments
Right arrow Alert me when this article is cited
Right arrow Alert me when TRACK Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by King, D. E.
Right arrow Articles by Geesey, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, D. E.
Right arrow Articles by Geesey, M. E.

Effect of Psyllium Fiber Supplementation on C-Reactive Protein: The Trial to Reduce Inflammatory Markers (TRIM)

Dana E. King, MD1, Arch G. Mainous, PhD, III1,2, Brent M. Egan, MD3, Robert F. Woolson, PhD2 and Mark E. Geesey, MS1

1 Department of Family Medicine, Medical University of South Carolina, Charleston
2 Department of Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston
3 Department of Medicine, Medical University of South Carolina, Charleston

CORRESPONDING AUTHOR: Dana E. King, MD, MS, Department of Family Medicine, 295 Calhoun St, Medical University of South Carolina, Charleston, SC 29425, kingde{at}musc.edu

PURPOSE Recent evidence supports a significant association between the intake of dietary fiber and levels of inflammatory markers. The objective of this study was to determine whether daily fiber supplementation would reduce levels of inflammatory markers.

METHODS This study was a prospective randomized controlled trial at a single university medical center. Participants were overweight or obese adults with no history of heart disease. The intervention was psyllium supplementation at either 7 or 14 g/d for 3 months compared with no supplements in a control group. The main outcome measure was change in level of high-sensitivity C-reactive protein (hsCRP) concentration; secondary outcomes included changes in interleukin-6 (IL-6) levels, fibrinogen levels, and white blood cell (WBC) count. Protocol completers attended at least 2 visits and took more than 75% of the prescribed fiber dose.

RESULTS In this intent-to-treat analysis (n = 158), there were no significant differences between either of the 2 treatment groups and the control group in the amount of change in CRP, fibrinogen, or IL-6 levels or in WBC count (P>.05). In the analysis of protocol completers (n = 132), there also were no significant differences between the groups except for a small decrease in fibrinogen level in the high-fiber group (–6 mg/dL [–0.18 µmol/L] compared with 13 mg/dL [0.38 µmol/L] in the control group, P<.05).

CONCLUSION Psyllium fiber supplementation did not significantly reduce CRP levels in overweight or obese individuals in this trial, and changes in other markers were not consistent. Further research is needed to determine whether other fibers or nutrients can reduce inflammatory markers.

Key Words: Inflammation • dietary supplements • dietary fiber • C-reactive protein • psyllium




This article has been cited by other articles:


Home page
Ann Fam MedHome page
K. C. Stange
In This Issue: What Patients Value and How to Provide It
Ann. Fam. Med, March 1, 2008; 6(2): 98 - 99.
[Full Text] [PDF]

TRACK Comments:

Read all TRACK Comments

Bedside Biophysical Semeiotic Evaluation of Acute Phase Proteins
Sergio Stagnaro
Annals of Family Medicine, 1 May 2008 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Annals of Family Medicine.